Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$491,556
+$32,193 QoQ
Shares Held
8,531
+12.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,550
of 2,506 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SUMMITRY LLC holds $46,849,010 across 11 Drug Manufacturers - General names. BMY ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
75,057 | $27,179,640 | |
| 2 | JNJ |
Johnson & Johnson
|
51,089 | $12,975,073 | |
| 3 | LLY |
ELI LILLY & Co
|
1,711 | $2,052,224 | |
| 4 | ABBV |
AbbVie Inc.
|
4,563 | $1,148,233 | |
| 5 | BIIB |
Biogen Inc.
|
4,137 | $893,840 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,279 | $806,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
8,531 | $491,556 | |
| 8 | NVS |
Novartis AG
|
2,464 | $386,158 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $491,556 | 8,531 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $459,363 | 7,574 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $357,082 | 6,620 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $243,043 | 5,389 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $365,366 | 7,893 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $207,009 | 3,660 | Shares | Sole | 2025-02-12 | |
| 2023-03-31 | $201,276 | 2,904 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $227,793 | 3,166 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $234,739 | 3,302 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||